---
schema_version: "secwatch.filing_event.v1"
accession: "0001639691-23-000090"
form_type: "8-K/A"
ticker: "LIVN"
cik: "0001639691"
company_name: "LivaNova PLC"
filed_at: "2023-09-21T23:59:59+00:00"
generated_at: "2026-06-10T10:45:04.257319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# LivaNova Cardiopulmonary President Marco Dolci to retire Dec 31, 2023

## Summary
- Marco Dolci, President of the Cardiopulmonary Business Unit, announced retirement effective December 31, 2023.
- Dolci will remain in role until his retirement date, focusing on transition of duties.
- Retirement Settlement Agreement provides regular pay and benefits until retirement plus €860,000 lump sum under Italian law.
- Unvested equity awards continue to vest per their terms; agreement includes mutual releases and waivers.

## SEC filing metadata
- accession: 0001639691-23-000090
- form_type: 8-K/A
- ticker: LIVN
- cik: 0001639691
- company_name: LivaNova PLC
- filed_at: 2023-09-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000090/0001639691-23-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000090/livn-20230918.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001639691-23-000090
- JSON: https://secwatch.observer/filing/0001639691-23-000090.json
- Plain text: https://secwatch.observer/filing/0001639691-23-000090.txt

## Key facts
- Executive change
  Marco Dolci departed as President of the Company’s Cardiopulmonary Business Unit at LivaNova PLC.
  - Action: announced retirement
  - Role: President of the Company’s Cardiopulmonary Business Unit
  source text: On September 21, 2023, LivaNova PLC (the “Company”) reported that Marco Dolci, President of the Company’s Cardiopulmonary Business Unit, announced his intent to retire formally from the Company on December 31, 2023 (the “Retirement Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1639691/000163969123000090/0001639691-23-000090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.